Lentivirus-mediated LIGHT overexpression inhibits human colorectal carcinoma cell growth in vitro and in vivo.

about

Lentivirus-mediated LIGHT overexpression inhibits human colorectal carcinoma cell growth in vitro and in vivo.

Item

http://www.wikidata.org/entity/Q42673095

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Lentivirus-mediated LIGHT over ...... l growth in vitro and in vivo.

@en

Lentivirus-mediated LIGHT over ...... l growth in vitro and in vivo.

@nl

type

Item

label

Lentivirus-mediated LIGHT over ...... l growth in vitro and in vivo.

@en

Lentivirus-mediated LIGHT over ...... l growth in vitro and in vivo.

@nl

prefLabel

Lentivirus-mediated LIGHT over ...... l growth in vitro and in vivo.

@en

Lentivirus-mediated LIGHT over ...... l growth in vitro and in vivo.

@nl

P1476

Lentivirus-mediated LIGHT over ...... l growth in vitro and in vivo.

@en

P2093

Aihua Sui

http://www.w3.org/2001/XMLSchema#string

Chuanzhi Li

http://www.w3.org/2001/XMLSchema#string

Haibo Wang

http://www.w3.org/2001/XMLSchema#string

Ruyong Yao

http://www.w3.org/2001/XMLSchema#string

Shihai Liu

http://www.w3.org/2001/XMLSchema#string

Xiangping Liu

http://www.w3.org/2001/XMLSchema#string

Zheng Luo

http://www.w3.org/2001/XMLSchema#string

Zhuang Yu

http://www.w3.org/2001/XMLSchema#string

P2860

Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM/TR2, stimulates proliferation of T cells and inhibits HT29 cell growth

A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis

The lymphotoxin-beta receptor is necessary and sufficient for LIGHT-mediated apoptosis of tumor cells

LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator

LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer

Harnessing HIV for therapy, basic research and biotechnology.

Development of lentiviral vectors for gene therapy for human diseases.

Renewed interest in cancer immunotherapy with the tumor necrosis factor superfamily molecules.

Generation and characterization of a preventive and therapeutic HPV DNA vaccine

Human papillomavirus type 16 and 18 E7-pulsed dendritic cell vaccination of stage IB or IIA cervical cancer patients: a phase I escalating-dose trial.

P304

927-932

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2013.1505

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258057117

http://www.w3.org/2001/XMLSchema#string

P698

24137438

http://www.w3.org/2001/XMLSchema#string

P921

overexpression

P932

3796404

http://www.w3.org/2001/XMLSchema#string